. | . |
Leveraging microgravity to improve medical diagnostics by Staff Writers Kennedy Space Center FL (SPX) Jul 17, 2020
What if a single drop of blood were all that is needed to provide reliable medical diagnostics in any setting on-or even off-Earth? This week, NASA astronauts Douglas Hurley and Robert Behnken, who recently launched to the International Space Station (ISS) on the historic SpaceX Demo-2 mission, are working on an investigation from Boston-based biotech startup 1Drop Diagnostics to enhance a portable device that can run diagnostic tests from anywhere using just one drop of blood. 1Drop Diagnostics' device contains specially designed microfluidic chips, and the company is doing research on the ISS to better understand fluid flow through the chips' small channels. Results from the investigation, sponsored by the ISS U.S. National Laboratory, should allow 1Drop Diagnostics to improve chip design and function. Through their space-based research, 1Drop Diagnostics seeks to advance next-generation medical diagnostics that will reduce health care costs and provide better health outcomes for patients back on Earth.
Decentralizing Diagnostics The company's microfluidic chips are able to automatically detect multiple biomarkers once a drop of blood is applied. The drop activates a series of events driven by capillary fluid flow through small channels in the chips. The biochemical reactions taking place in the miniaturized chips occur in small volumes, which allows for increased test sensitivity and quicker results. Furthermore, all fluid processing steps are encoded in the chips, eliminating the need for additional equipment or manipulation.
Microfluidics in Microgravity By leveraging microgravity-driven changes in fluid dynamics, 1Drop Diagnostics hopes to gain insight that will help improve fluid control in their microfluidic chips. Results from this research could also aid in the design of microfluidic chips that are portable and rugged because they function in any orientation and are better able to absorb shock. The investigation from 1Drop Diagnostics is the second project that stemmed from the MassChallenge Boston Accelerator that NASA astronauts Hurley and Behnken have worked on since their arrival onboard the space station-the pair also worked on an investigation from Cam Med Inc. to enhance a new drug delivery device. Hurley and Behnken became the first astronauts launched to the space station through NASA's Commercial Crew Program via the SpaceX Demo-2 mission in late May. This mission ushered in a new era in human spaceflight-representing the first time American astronauts were launched into orbit from U.S. soil in nearly a decade and the first time ever onboard a commercially owned spacecraft.
Space-equipped lab tests key workers for COVID-19 Paris (ESA) Jul 01, 2020 Space-enabled tests are underway to empower healthcare workers, civil protection volunteers and members of the emergency services to help other people. As the immediate crisis caused by the coronavirus pandemic fades in Europe, extensive testing systems are needed to enable the vital economic recovery. An ESA-backed mobile field laboratory set up at Piedmont is enabling the Italian authorities to test thousands of key workers for COVID-19. Some of the tests carried out there take just a few ... read more
|
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |